TCL Archive FDA Advisory Committee Recommends Approval Of Ifosfamide as Third Line Therapy For Testicular Cancer April 29, 1988
TCL Archive In Brief: Treatment Reorganization Plan Due In November, Rauscher Says; Panel To Review Clinical Activities June 27, 1975
TCL Archive Richard Klausner resigned from the Gates Foundation, saying move was unrelated to Congressional investigation of NCI contract to Harvard University during Klausner’s tenure as NCI director. September 16, 2005